Cilostazol may Reduce Risk of Restenosis After Carotid Stenting, suggests research Dr Riya Dave1 Jan 2025 9:15 AM ISTRecent research has proven that supplementing antiplatelet therapy with cilostazol minimizes in-stent restenosis (ISR) in carotid artery stenting...
Long-term benefits of 12-months DAPT post-CABG revealed in DACAB trial follow-up Medha Baranwal19 Jun 2024 8:45 AM ISTChina: A landmark clinical trial, known as DACAB, has unveiled significant findings regarding antiplatelet therapy use following coronary artery...
Intravenous Tirofiban Reduces Neurological Deterioration in Acute Noncardioembolic Stroke: JAMA Dr Riya Dave24 April 2024 8:30 PM ISTResearchers have found that intravenous tirofiban, administered within 24 hours of stroke onset, decreases the risk of early neurological...
Antiplatelet Therapy may Reduce COVID-19 Severity and Complications: Study Jacinthlyn Sylvia4 March 2024 3:30 AM ISTA recent study published in the Nature Scientific Reports uncovered the role of antiplatelet therapy (AP) in reducing the severity of the COVID-19 and...
Continuous DAPT raises GI bleeding risk even in low risk patients after PCI: JAMA Medha Baranwal21 Nov 2023 11:30 AM ISTChina: Findings from a recent study published in JAMA Network Open have suggested an increased risk of gastrointestinal bleeding (GIB) with continuous...
Optimum antithrombotic therapy for primary and secondary prevention of ischemic stroke- Salient features Medha Baranwal11 Oct 2023 11:00 AM ISTUSA: A recent state-of-the-art review published in the Journal of the American College of Cardiology has provided a comprehensive summary of the...
Ticogrelor monotherapy associated with similar rates of revascularization as DAPT after PCI Dr. Kamal Kant Kohli22 May 2023 10:00 AM ISTNew insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar...
IL-6 receptor antagonists and antiplatelet agents improve survival among critically ill COVID-19 patients Dr.Niharika Harsha B21 Dec 2022 11:15 AM ISTPatients who are critically ill with COVID-19 infection had a 99.9% probability of improved 180-day mortality compared to placebo when treated with...
Ticagrelor-aspirin antiplatelet therapy more beneficial in persons with normal renal function Dr. Kamal Kant Kohli1 Nov 2022 2:45 AM ISTAn analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with...
Asundexian promising oral anticoagulant in post-myocardial infarction patients Dr. Kamal Kant Kohli15 Sept 2022 8:00 PM ISTResearchers have found in a new study that Asundexian was a promising oral anticoagulant in post-myocardial infarction patients.Asundexian 50 mg...
New anticoagulant asundexian prevents recurrent ischaemic stroke without increasing bleeding: PACIFIC-Stroke Dr. Kamal Kant Kohli31 Aug 2022 9:45 AM ISTNew anticoagulant asundexian prevents recurrent ischaemic stroke without increasing bleeding risk according to PACIFIC-Stroke trial. Further...
Management of patent foramen ovale: SCAI issues new official guidelines Dr. Kamal Kant Kohli20 May 2022 7:00 PM ISTATLANTA: The Society for Cardiovascular Angiography & Interventions (SCAI) today released official guidelines for the management of patent foramen...
